Founder
Timothy Cherotti
Timothy cherotti
Serial entrepreneur, founder, and investor who has a pedigree of identifying unrealized potential, building operational value and monetization. With a knack for building businesses, he has driven the growth of many tech organizations over the last several years via both personal investments and spearheading capital raises.
Timothy Cherotti is a distinguished entrepreneur, investor, and strategic visionary known for his ability to build, scale, and exit high-growth ventures across diverse industries. With a hands-on leadership style, he goes beyond capital deployment—actively driving operational value and long-term profitability in every venture he leads.
As the Founder and CEO of Pharma GenLabs, Cherotti is at the forefront of the pharmacogenomics revolution. His company leverages genetic insights to personalize drug therapies, aiming to improve patient outcomes while minimizing adverse drug reactions. Under his leadership, Pharma GenLabs is redefining modern healthcare by integrating genomics into everyday medical practice.
Cherotti’s track record as an early-stage investor is equally impressive. He was a visionary seed investor in TouchCast, backing the company when it held a $25 million valuation. His belief in immersive technology and its potential to transform communication proved prescient—Infinite Reality acquired TouchCast in 2025 for $500 million. This strategic win highlights his ability to identify and support groundbreaking innovations with major growth potential.
Previously, Cherotti served as Founder and CEO of ConstructionLabor.com, a pioneering employment platform that matched contractors with skilled tradesmen across the United States. He developed and launched two proprietary software systems that fueled the company’s growth to a $104 million valuation, culminating in a strategic partnership with Silver Oak. As Chairman of the Board, he led the company through a successful acquisition by Blackstone in 2019.
Timothy is also a seed investor in IR Scientific, a cutting-edge oral care company focused on revolutionizing sensitivity toothpaste. By combining advanced technology with a deep understanding of consumer needs, IR Scientific is set to transform how people experience and treat dental sensitivity.
Whether launching disruptive ventures or backing breakthrough technologies, Timothy Cherotti continues to shape the future through innovation, insight, and execution.
